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ABSTRACT 
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia. It is caused by impaired insulin 
secretion or by insulin receptor insensitivity. DM and its complications are often related to increases in the level of 
oxidative stress. Spirulina is a nutrient-dense food that contains an abundance of antioxidant compounds. In combination 
with kefir, it may serve as both a nutrient-rich diet and an antioxidant agent that can prevent complications of diabetes. This 
study aims to investigate the nutritional content of kefir-spirulina and its effect on glycemic status and antioxidant activity 
in streptozotocin-nicotinamide (STZ-NA) induced diabetic rats. A total of 30 male Sprague Dawley rats were divided into 
five groups: normal control (K1), diabetic control (K2), pioglitazone treatment (K3), kefir combined with 1% spirulina 
treatment (P1), and kefir combined with 2% spirulina treatment (P2). All rats were induced by STZ-NA, except for the 
normal control. Before and after the 28 days of intervention, blood samples were taken and analyzed for fasting plasma 
glucose, postprandial glucose, and SOD activity. The nutritional content, ethanol content, and total antioxidant capacity of 
kefir-spirulina were also analyzed. The diabetic rats that were fed with kefir-spirulina (P1 and P2) had a significant 
decrease in both fasting and postprandial plasma glucose (p <0.001) compared to the diabetic control rats. The decrease of 
plasma glucose in K2 is comparable to the control rats treated with the diabetic drug pioglitazone (K3). The activity of 
SOD in diabetic rats fed in P1 and P2 were higher (p <0.001) than in untreated diabetic rats (K2). The IC50 of kefir-
spirulina was 42 – 43 ppm. It was concluded that kefir combined with spirulina has high nutrition and antioxidant capacity, 
which is proven to be capable of controlling glycemic status and enhancing antioxidant status in a diabetic rat model. 
Keywords: kefir; spirulina; antioxidant; hyperglycemia; SOD 
INTRODUCTION 
 Diabetes mellitus (DM) is a metabolic disorder 
characterized by chronic hyperglycemia, impaired insulin 
secretion, insulin resistance, and β cell dysfunction. The 
common characteristic symptoms include thirst, polyuria, 
polyphagia, blurring of vision, and weight loss (WHO, 
1999). The International Diabetic Federation (IDF) 
reported that approximately 451 million individuals 
suffered from DM in 2017, and this number is predicted to 
increase to 693 million in 2045 (Cho et al., 2018). The 
mortality rate in 2017 of individuals aged 20 – 99 was  
5 million, and this figure will continue to increase 
worldwide, creating a global health burden. 
 Hyperglycemia induces free radicals production and 
defects in the endogenous antioxidant defense mechanism, 
resulting in oxidative stress (Moussa, 2018; Schultz 
Johansen et al., 2005). Free radicals such as reactive 
oxygen species (ROS) can be generated through many 
processes, including glucose auto-oxidation, change of 
redox balance, reduction of antioxidant concentration, and 
failure of antioxidant enzyme activity. ROS leads to 
oxidative damage to various biomolecules in the cell, such 
as proteins, lipids, and nucleic acids. ROS oxidizes the 
polyunsaturated fatty acids (PUFA) in the cell membranes 
and generate hydrogen peroxides. These hydrogen 
peroxides could undergo fragmentation, creating reactive 
intermediates, such as prostaglandin, isoprostane, and 
malondialdehyde (MDA) (Catalá, 2009). The 
accumulation of ROS could induce macromolecules' 
glycation and may cause chronic complications in DM 
such as retinopathy, nephropathy, atherosclerosis, and 
coronary heart disease (Schultz Johansen et al., 2005; 
Matough et al., 2012). 
 The high levels of ROS are commonly accompanied by 
the impairment of various antioxidant enzymes, such as 
catalase, glutathione peroxidase (GSH-Px), and superoxide 
dismutase (SOD) (Moussa, 2018). These enzymes are 
critical in clearing the free radicals generated in the body. 
SOD, for example, is an essential antioxidant enzyme 
capable of preventing damage to macromolecular 
components of cells and repairing free radical compounds 
(Valko et al., 2007). 
 The clinical management of DM controls glycemic status 
by consuming diabetic drugs either orally or by injection. 
However, this approach could increase complications such 
as hyperinsulinemia and infection (Gedawy et al., 2018; 
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Santaguida et al., 2005). Limitation in drug treatment 
encourages an alternative approach to DM management. 
There has been a growing body of evidence that functional 
foods and probiotics have beneficial effects on DM 
management (Venkatakrishnan, Chiu and Wang, 2019). 
Various foods rich in nutrients and bioactive compounds 
such as fruits, vegetables, legumes, probiotics, and 
fermented foods have shown promising results in 
controlling glycemic status and decreasing oxidative stress 
(Barengolts et al., 2019; Habib and Parvin, 2008). 
 Kefir is fermented milk containing approximately  
52 types of lactic acid bacteria and yeast (Pogačić et al., 
2013). It is widely used as a medication to treat various 
illnesses in middle Asian countries (Kýlýc et al., 1999). 
Kefir acts as antioxidants that are capable of enhancing 
SOD, GSH-Px, and catalase activity (Judiono, 
Djokomoeljanto and Hadisaputro, 2011). 
 In this study, we aimed to explore kefir's potential as  
functional food for controlling glycemic status and 
antioxidant status in DM modeled rats. To enhance the 
kefir activity and nutrition, we combined kefir with 
spirulina, nutrient-rich microalgae. Having high protein 
content (60 – 70%) (Sadeghi et al., 2018) and various 
bioactive compounds (Wu et al., 2005), spirulina has 
shown effectivity in controlling blood glucose (Sadeghi et 
al., 2018; Senthil, Balu and Murugesan, 2013) and the 
level of oxidative stress (Niccolai et al., 2019; Layam 
and Reddy, 2007). 
 
Scientific hypothesis 
 This study hypothesizes that a combination of kefir and 
spirulina could serve as a novel functional food in DM 
management through controlling glycemic status and 
antioxidant capacity in a diabetic rat model. 
 
MATERIALS AND METHODOLOGY 
Statement of ethics 
 This research obtained ethical approval with Ethical 
Clearance 152/EC/H/KEPK/FK-UNDIP/XII/2019 Faculty 
of Medicine, Diponegoro University, Semarang, 
Indonesia. 
 
Chemicals and reagents 
 All the chemicals used were of the highest purity grade. 
Streptozotocin (STZ) and nicotinamide (NA) were 
purchased from Nacalai Tesque, Inc. (Kyoto, Japan). 
Chloric acid, sulphuric acid, potassium sulfate, copper 
sulfate, ethanol, methanol, demineralized water, potassium 
hydroxide, and acetone were purchased from Merck. A kit 
for the glucose assay (GOD-PAP) was procured from 
DiaSys, Holzheim, Germany. A kit for estimation of SOD 
activity was procured from BioVision, Inc. 
 
Preparation of kefir-spirulina 
 Spirulina was obtained from PT Neoalgae Sukoharjo, 
Central Java. Spirulina generally contains 60 – 70% total 
protein, including essential amino acids such as leucine, 
isoleucine and, valine. It has 4 – 7% lipids, essential fatty 
acids such as linoleic and γ-linolenic acid, and ω-3 and  
ω-6 polyunsaturated fatty acids. It also contains provitamin 
A, vitamin B12, and β-carotene (Koru, 2012). 
 Kefir-spirulina was made by combining 1% cow's milk 
with either 1% (w/v) or 2% (w/v) spirulina, followed by 
pasteurization. Kefir grain (5%) was added to the solution 
after it cooled down, followed by incubation at room 
temperature (25 – 37 °C) for 24 hours (Figure 1). After 
separating the grain from the solution, the kefir-spirulina 
mixture was analyzed for its nutritional content, ethanol 
content, and antioxidant capacity. 
 
Nutrient analysis 
 Nutrient analysis was performed according to the 
standard official methods of the Association of Official 
Analytical Chemists procedures 2005 (AOAC, 2005). 
Nutritional parameters such as moisture, protein, fat, ash, 
carbohydrate, and fiber were determined. 
 
Moisture content  
 Approximately 2 g of the sample (W1) was placed on  
a dish and dried in an oven for 5 hours at 95 – 105 °C. 
After drying, the dish was transferred to a desiccator to 
cool, and the sample was subsequently reweighed (W2). 




W1 	× 	100% 
 
W1 = weight (g) of the sample before drying, 
W2 = weight (g) of the sample after drying. 
 
Ash content 
 A drying method was used to assay the ash content. 
Briefly, 1 g of the sample was placed in a silica crucible. 
The sample was spread in an even layer and placed in  
a muffle furnace. The furnace temperature was allowed to 
reach a temperature of 550 °C for approximately 2 hours 
or until the sample turned white or slightly grey. The ash 




Weight	of	the	sample 	× 	100% 
 
Crude fat content 
 Fats were determined by the intermittent Soxhlet 
extraction method. A flask was weighed as an initial 
weight. A 2 g sample was placed in the fat sleeve. The 
sample and 200 mL of chloroform were added to the 
Soxhlet flask apparatus. The flask was then placed in an 
oven at 105 °C for 2 hours, then cooled in a desiccator. 





Wt. of	sample 	× 	100% 
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Crude protein content 
 Protein content in the sample was determined by the 
Kjeldahl method according to (Afifah et al., 2019) with 
some modification. A 2 g sample was digested by adding 
15 mL of concentrated H2SO4 and two tablets of catalyst. 
The solution mixture was boiled until the solution was 
clear. The solution was filtered into a volumetric flask and 
connected for distillation. Ammonia was steam distilled 
from the solution, to which 50 mL of 45% sodium 
hydroxide solution had been added. 150 mL of the 
distillate was collected in a flask containing 100 mL of  
0.1 N HCl and methyl red indicator. The ammonia-
containing distillate reacted with the acid, and the excess 
acid in the flask was estimated by back titration against  
2.0 M NaOH. 
 
Carbohydrate 
 Total carbohydrate content was calculated as an 
approximation percentage with the following formula: 
 
(%) Carbohydrate = 100%− [Protein(%) +
Moisture		(%) + Ash		(%) + Fat		(%) 
 
Dietary fiber content 
 The sample (2 – 3 g) was mixed with 50 mL of 1.25% 
H2SO4 in a flask for 30 minutes. An amount of 50 mL 
NaOH (3.25%) was added to the mixture, then boiled. The 
mixture was filtered through a Buchner funnel containing 
Whatman paper and washed with 1.25% H2SO4, hot water, 





𝑾𝟏 	× 	𝟏𝟎𝟎% 
 
Ethanol content  
 The ethanol content in the sample was determined using 
high-performance liquid chromatography (HPLC), 
according to (Dias et al., 2020). Water as a mobile phase 
was used together with column YMC-Triat C8 (150 mm × 
4.6 mm, particle size: 5 μm). 20 μL of the sample was run 
with 1 mL.min-1 flowrate at 40 °C for 15 minutes. 
 
Antioxidant activity 
 Antioxidant activity was determined based on  
2,2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging 
activity. The kefir sample was diluted in methanol absolute 
and mixed well. A series of sample concentrations of  
5 ppm, 10 ppm, and 20 ppm were diluted with methanol 
absolute up to 5 mL, after which 1 mL of 0.4 mM DPPH 
solution was added. The mixture was shaken vigorously 




 Figure 1 Fermentation process of kefir with 1% and 2% of spirulina. 
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and the absorbance was measured at 517 nm. Trolox with 







 The concentration of kefir-spirulina providing 50% 
inhibition(IC,-)	was calculated from the plotted graph of 
kefir-spirulina concentration and percentage of inhibition. 
The IC,-	value was then estimated using the fitted line 
(Hendel, Larous and Belbey, 2016). 
 





 The sample used in this study was a male Sprague 
Dawley Rattus novegicus aged 8 weeks, weighing 
approximately 150 – 200 g. The animals were acclimatized 
for one week in a temperature-controlled room  
(20 ‒ 25 °C) and maintained on a 12 h light/12 h dark 
cycle. They were allowed free access to a standard 
commercial diet (Comfeed II, Japfa) and tap water. A total 
of 30 male Sprague Dawley rats were divided into five 
groups: normal control (K1), diabetic control (K2), 
pioglitazone treatment (K3), kefir combined with  
1% spirulina treatment (P1), and kefir combined with  
2% spirulina treatment (P2). All rats were induced by 
streptozotocin-nicotinamide (STZ- NA), except for the 
normal control. Nicotinamide (NA) was dissolved in saline 
solution and given intraperitoneally (i.p.) at a dose of  
110 mg.kg-1 body weight. After 15 minutes, the rats were 
induced by 45 mg.kg-1 body weight of streptozotocin 
(STZ) in citrate buffer (i.p.). The rats considered having 
diabetes if three days after induction the fasting blood 
glucose was more than 126 mg.dL-1 and plasma glucose 
were more than 200 mg.dL-1. Groups P1 and P2 received 
kefir-spirulina via gavage with a total dose of 3 mL.200g-1 
body weight per day orally for 28 days. Group K3 received 
the diabetes drug pioglitazone at a dose of 0.27 mg.200g-1 
body weight per day orally for 28 days. 
 Before and after the 28 days of intervention, blood 
samples were taken through the retro-orbital sinus and 
were analyzed for fasting plasma glucose, postprandial 
glucose, and SOD activity. 
 
Blood glucose test 
 Fasting and postprandial blood glucose were determined 
using the Glucose Oxidase Phenol 4-Aminoantipyrine 
Peroxidase (GPO-PAP) according to the kit (DiaSys, 
Holzheim, Germany). Briefly, 10 µL of blood plasma was 
mixed with 1000 µL of reagent, then incubated for  
20 minutes at 20 – 25 °C. The absorbance was read at  
505 nm (System, 2012). 
 
Analysis of SOD activity 
 SOD activity was measured via the WST method using  
a kit by BioVision. Briefly, 20 µL of blood plasma was 
mixed with 200 µL of WST solution, 20 µL of dilution 
buffer, and 20 µL of the SOD working solution. The 
mixture was then incubated for 20 minutes at 37 °C, and 
absorbance was read at 450 nm (SOD Assay, 2019). 
 
Statistical analysis 
 Statistical analyses were performed using SPSS version 
24 (IBM, 2016). The obtained data were analyzed using 
Shapiro-Wilk since the data were normally distributed. 
The paired t-test and one-way ANOVA were used to 
determine the effect of experimental treatments. 
Differences were considered to be significant if p-values 
less than 0.05 (p <0.05). In the case of variance 
homogeneity p >0.05, post-hoc LSD was used; otherwise, 
post-hoc Tamhane was used. 
 
RESULTS AND DISCUSSION 
Nutrient content 
 Table 1 showed the nutrient content of the two 
formulations of kefir-spirulina. The water content was 
93.82% and 92.67% for formulas A and B, respectively. 
The high water content in the two formulations was due to 
the clear part of the kefir used in the formulation, while the 
curd was separated. Our result is in line with several other 
studies that showed that kefir generally contained  
89 – 90% water (Sarkar, 2007; Plessas et al., 2017). 
 The ash content for the kefir formulation was similar, at 
0.76% (formula A) and 0.72% (formula B). Our results 
were comparable with several other studies that found ash 
content was around 0.7 – 1.1% (Arslan, 2014; Plessas et 
al., 2017; Rosa et al., 2017). 
 The two kefir formulations prepared in this study 
contained 4.02% and 5.53% protein, almost twice the 
minimum amount suggested by CODEX STAN 234-2003 
(FAO, 2010). It has been shown previously that kefir 
usually contains 3% of protein (Sarkar, 2007; Plessas et 
al., 2017; Magalhães et al., 2011). The improvement of 
the protein content of the kefir prepared in this study is 
likely due to the addition of spirulina, which is rich in 
protein (circa 60 – 70% of its dry weight) (Wu et al., 
2005). The addition of 2% spirulina to the kefir showed 
higher protein content than the addition of 1% spirulina. 
 The carbohydrates content of kefir-spirulina for formula 
A and B were 1.56% and 1.12%, respectively. These 
results are lower than previous studies indicating that kefir 
contains carbohydrates between 3.8% and 4.7% (Arslan, 
2014). The fiber content in this study's kefir formulations 
was 2.49% (formula A) and 6.40% (formula B). Fiber is  
a nonstarch polysaccharide with high nutritional value; the 
high fiber content in spirulina will slow down the glucose 
absorption in the ileum, thereby lowering postprandial 
glucose (Hernández-Alonso et al., 2017; Chandalia et 
al., 2000). 
 Fat content in the kefir formulations was 1.04% (formula 
A) and 0.59% (formula B). The low level of fat found in 
our kefir formulations was presumably due to lipase 
activity, which was produced by lactic acid bacteria 
(BAL). This study's fat content is relatively higher 
compared to the 0.2% that was shown in previous studies 
(Sarkar, 2007; Plessas et al., 2017). Fat content in the 
kefir could vary depending on the type of milk used in the 
fermentation process (Otles and Cagindi, 2003). 
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 Table 1 The nutritional content of the two formulations of kefir-spirulina. 
Formulation Water  Protein  Fat  Ash  Carbohydrate  Fiber  
 (%) 
(A) Kefir with 1% 
spirulina  
93.82 ±0.17 4.02 ±0.22 0.20 ±0.05 0.76 ±0.04 1.56 ±0.22 2.49 
(B) Kefir with 2% 
spirulina  
92.67 ±0.47 5.53 ±0.22 0.29 ±0.07 0.72 ±0.08 1.12 ±1.17 6.40 
 
 
 Table 2 Ethanol content and antioxidant activity of kefir-spirulina. 
Formulation Ethanol (%) IC50 (ppm) 
(A) Kefir with 1% spirulina 0.59 43.65 ±0.15 
(B) Kefir with 2% spirulina 0.65 42.00 ±0.08 
 
 
 Table 3 The average body weight of the experimental animals. 
Group Body weight (g) ±SD pb 
Pre-treatment Post-treatment Delta pre-post 
K1 (Normal control) 187.67 ±12.59 199.33 ±22.28 11.66 ±17.68 0.249 
K2 (Diabetic control) 166.17 ±4.17 151.00 ±4.73 -15.17 ±1.33 0.026* 
K3 (Diabetic + Pioglitazone) 166.17 ±10.87 173.67 ±15.82 12.50 ±21.57 0.173 
P1 (Diabetic + Kefir with 1% spirulina) 170.67 ±17.69 172.17 ±7.88 1,50 ±23.85 0.462 
P2 (Diabetic + Kefir with 2% spirulina) 188.67 ±32.44 198.67 ±24.24 10.00 ±37.54 0.893 
pa 0.023* 0.001* 0.066  
Note: aWilcoxon; bKruskal-Wallis; *Significant (p <0.05). 
 
 
 Table 4 Fasting blood glucose levels (mg.dL-1). 
Group Average fasting blood glucose ± SD pb 
Pre-treatment Post-treatment Delta pre-post 
K1 (Normal control) 69.37 ±1.25 71.17 ±2.51 1.80 ±1.91 0.069 
K2 (Diabetic control) 263.42 ±2.98 265.53 ±2.43 2.10 ±1.31 0.011* 
K3 (Diabetic + Pioglitazone) 268.05 ±3.27 99.35 ±2.90 -168.70 ±4.41 0.000* 
P1 (Diabetic + Kefir with 1% spirulina) 270 ±3.03 150.62 ±1.43 -119.44 ±1.96 0.000* 
P2 (Diabetic + Kefir with 2% spirulina) 266.98 ±4.36 105.89 ±3.61 -161.09 ±7.11 0.000* 
pa 0.000* 0.000* 0.000*  
Note: aOne-Way ANOVA; bPaired t-test; *Significant (p <0.05). 
 
 
 Table 5 Postprandial blood glucose (mg.dL-1). 
Group Average postprandial blood glucose ± SD pb 
Pre-treatment Post-treatment Delta pre-post 
K1 (Normal control) 77.92 ±1.80 81.26 ±1.98 3.34 ±0.97 0.000* 
K2 (Diabetic control) 278.58 ±3.25 274.06 ±2.64 -4.52 ±2.64 0.010* 
K3 (Diabetic + Pioglitazone) 281.38 ±3.74 110.71 ±3.77 -170.67 ±5.23 0.000* 
P1 (Diabetic + Kefir with 1% spirulina) 283.52 ±1.74 170.05 ±2.96 -112.47 ±1.62 0.000* 
P2 (Diabetic + Kefir with 2% spirulina) 280.24 ±4.36 126.18 ±4.03 -154.12 ±7.09 0.000* 
pa 0.000* 0.000* 0.000*  
Note: aOne-Way ANOVA; bPaired t-test; *Significant (p <0.05). 
 
 Table 6 SOD Activity (U.mL-1). 
Group Average SOD activity ± SD pb 
Pre-treatment Post-treatment Delta pre-post 
K1 (Normal control) 84.89 ±3.37 83.60 ±3.87 -1.29 ±1.36 0.068 
K2 (Diabetic control) 18.61 ±2.45 25.00 ±3.09 6.39 ±4.99 0.026* 
K3 (Diabetic + Pioglitazone) 24.48 ±4.26 72.95 ±3.06 48.47 ±5.63 0.000* 
P1 (Diabetic + Kefir with 1% spirulina) 25.00 ±5.32 50.82 ±3.74 25.81 ±5.93 0.000* 
P2 (Diabetic + Kefir with 2% spirulina) 23.43 ±4.07 65.30 ±4.06 41.86 ±6.82 0.000* 
pa 0.000* 0.000* 0.000*  
Note: aOne-Way ANOVA; bPaired t-test; *Significant (p <0.05). 
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Ethanol content 
 One of the main products of kefir fermentation was 
ethanol. The kefir-spirulina prepared in this study has  
a relatively low ethanol content (Table 2), which was 
0.59% (formula A) and 0.65% (formula B). Ethanol in the 
kefir is usually in the range of 0.5 – 2.0% (Rosa et al., 
2017;  Karaçalı, Özdemİr and Çon, 2018). Foods or 
beverages with low ethanol content are beneficial, 
especially in a country with religious restrictions regarding 
foods and beverages containing alcohol. The lactose 
fermentation of kefir generated ethanol, which contributed 
to the kefir's characteristic aroma (Ertekin and Guzel-
Seydim, 2010). Generally, the level of ethanol in kefir is 
influenced by yeast metabolism and heterofermentative 
bacteria that produce ethanol (Farnworth, 2008). 
 
Antioxidant activity 
 The antioxidant activity of kefir-spirulina in this study 
was determined based on DPPH radical scavenging 
activity and presented as half-maximal inhibitory 
concentration IC50. The average total antioxidant activity 
of kefir-spirulina showed relatively strong activity, with 
IC50 of 43.65 ppm and 42.00 ppm, for formulas A and B, 
respectively (Table 2). An antioxidant is considered to be 
very strong if the IC50 is less than 50 ppm, strong if IC50 is 
50 ppm – 100 ppm, weak if IC50 is 150 ppm – 200 ppm, 
and very weak if IC50 is more than 200 ppm (Molyneux, 
2004; Badarinath et al., 2010). 
 Kefir has been known to contain various antioxidant 
compounds capable of binding free radicals, decreasing the 
malondialdehyde concentration, and increasing glutathione 
peroxidase, thus regulating the level of oxidative stress 
(Rosa et al., 2017). Antioxidant activity in kefir-spirulina 
increased during the fermentation process. The proton of 
the acids produced by lactic acid bacteria during 
fermentation can be donated to the free radicals, increasing 
the primary antioxidant capacity (Waris and Ahsan, 
2006). 
 
Bodyweight of experimental rats 
 The rats' body weight during the whole experiment 
(before and after treatment) is shown in Table 3. After  
7 days of acclimatization, all rats except for the normal 
control (K1) were induced by STZ-NA. After 3 days, all 
diabetic rats received treatments for 28 days, except for the 
negative control (K2). Rats in diabetic control groups (K2) 
experienced a decrease in their body weight (p <0.05). 
This result is not surprising since STZ-NA induction may 
cause physiological changes and alteration in energy 
metabolism, affecting body weight. STZ induction may 
damage the pancreas. The pancreas' function is to 
synthesize and secrete insulin, which is vital in glucose 
utilization and, eventually, energy production.  
A disruption in insulin production causes a disturbance in 
energy homeostasis. As compensation, the body will shift 
towards fat and protein metabolism and may cause weight 
loss (Szkudelski, 2001). When diabetic rats were treated 
with the diabetic drug (K3) or kefir-spirulina (P1 and P2), 
body weight was compensated. We found no significant 
body weight changes (p >0.05) in diabetic rats treated with 
kefir-spirulina (P1 and P2) or with diabetic drugs (K3). 
Kefir has an immunomodulatory effect capable of 
improving intestinal microflora and absorption, therefore 
improving body weight (Judiono, Djokomoeljanto and 
Hadisaputro, 2010). 
 
Fasting and postprandial glucose analysis 
 Table 4 compares the changes in fasting plasma glucose 
levels in the five groups. The rats' blood glucose level in 
the normal control (K1) remained relatively stable at  
a normal level. In contrast, diabetic rats with no treatment 
(K2) suffered from consistently high glucose levels. The 
effect of 28 days of administration of kefir-spirulina 
(P1and P2) or the diabetic drug pioglitazone (K3) on the 
diabetic rats significantly decreased the glucose level  
(p <0.001). Pioglitazone reduced blood glucose by 
improving glucose uptake in peripheral tissue and 
eventually enhanced insulin sensitivity (Waugh et al., 
2006). On the other hand, kefir's ability to control plasma 
glucose levels has been shown through several studies 
(Nurliyani, Harmayani and Sunarti, 2015; Bellikci-
Koyu et al., 2019). Kefir contains bioactive components 
such as peptides, short-chain fatty acids (SCFA), and 
exopolysaccharides (EPSs) that could affect the plasma 
glucose level. EPSs can increase cAMP concentration on 
Langerhans' islands so that the pancreas can increase 
insulin secretion (Al-Shemmari, Kassim Altaee and 
Hassan, 2018). It also activates glucagon-like peptide  
1 (GLP 1) and gastric inhibitory peptide (GIP), which 
subsequently enhances insulin secretion (Al-Shemmari, 
Kassim Altaee and Hassan, 2018; Hadisaputro et al., 
2012; Judiono, Djokomoeljanto and Hadisaputro, 
2011; El-Bashiti, Zabut and Abu Safia, 2019). 
Furthermore, EPSs have also been proved to have 
antioxidant properties through free radical scavenging 
activity (Mao et al., 2014), which gives protection from 
oxidative damage that occurred on pancreatic cells. The 
high protein content in the kefir has an indirect role in 
regulating glucose levels through the regeneration and 
maintenance of pancreatic β cells (Hulston, Churnside 
and Venables, 2015). SCFAs, on the other hand, are 
produced by the activities of probiotic microorganisms 
present in the kefir grain (Simova et al., 2002). SCFA 
were thought capable of protecting pancreatic β-cells, 
increasing enzymatic antioxidant activity, and improving 
insulin resistance through regulating the expression of 
tumor necrosis factor-alpha (alpha TNFα) and nuclear 
factor-kappa B (NF-kB) (Wang et al., 2017). 
 As expected, combining spirulina and kefir improved the 
ability to control glucose levels. Increasing the spirulina 
composition by a factor of two (formula B on group P2) 
improved the ability of kefir-spirulina to lower the glucose 
level (glucose changes of P1 vs P2 were 112.47 mg.dL-1 vs 
154.12 mg.dL-1; post-hoc test (p <0.05). This result 
indicated the synergistic effect of bioactive compounds 
present in the kefir-spirulina formulation. The synergistic 
effect of modified kefir has also been shown in several 
other studies (Nurliyani, Harmayani and Sunarti, 2015; 
Judiono, Djokomoeljanto and Hadisaputro, 2011). 
Spirulina consists of several bioactive compounds such as 
phycocyanin, carotenoids, vitamin E, chlorophyll, 
flavonoids, saponins, and phenolic compounds 
(Okechukwu et al., 2019). The C-phycocyanin (C-PC) 
peptide activates the insulin signaling pathway, regulates 
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glucokinase expression in the pancreas and liver, and 
protects pancreatic β cells (Li et al., 2020). Previous 
studies showed that spirulina consumption could reduce 
blood glucose levels (Huang et al., 2018; Aissaoui et al., 
2017; Jarouliya et al., 2015). Spirulina reduced blood 
glucose levels by stimulating β cell activity and increasing 
glucose transport to peripheral tissues (Layam and 
Reddy, 2007). Moreover, it has high fiber content, which 
slows down macronutrients' digestive process 
(Hernández-Alonso et al., 2017), thus maintaining the 
plasma glucose level. 
 We also analyzed postprandial glucose levels. Compared 
with fasting glucose, postprandial glucose level was 
thought to be better associated with the risk factor of 
diabetes and the level of HbA1c (Haddadinezhad and 
Ghazaleh, 2010), which reflects the glycemic control in 
diabetes patients over a certain period. According to the 
American Diabetes Association (ADA), the recommended 
postprandial glucose level for diabetes patients is below 
180 mg.dL-1 (ADA, 2018). The postprandial glucose levels 
of the five groups are presented in Table 5. In general, the 
changes in postprandial glucose of all groups are in 
agreement with the results obtained in fasting glucose 
levels. As can be seen in Table 5, treatment with 
pioglitazone (K3) and kefir-spirulina (P1 and P2) 
successfully reduced (p <0.001) the postprandial glucose 
concentration to less than 180 mg.dL-1 (K3 = 110 mg.dL-1, 
P1 = 170 mg.dL-1, and P2 = 126 mg.dL-1). The ability of 
kefir to reduce postprandial glucose has also been shown 
in other studies (Alsayadi et al., 2014). The biggest 
changes in postprandial glucose levels in this study were 
observed in group P2, which was treated with kefir 
combined with 2% spirulina (formula B). 
 
SOD Activity 
Table 6 shows the changes in the SOD activity of the 
experimental groups. Administration of kefir-spirulina in 
groups P1 and P2 significantly increased SOD levels  
(p <0.001). The increase in SOD activity was 48.47 U.mL-
1, 41.86 U.mL-1, and 25.86 U.mL-1 for groups K3, P2, and 
P1, respectively. There is some background increase  
(6.39 U.mL-1) in the negative control group (K2), while the 
normal control group (K1) showed a relatively constant 
SOD activity (p >0.05). A study by Omayma et al. (2013) 
showed that fermented soy could normalize the SOD and 
glutathione peroxidase (GPx) activities in rat tumor tissue. 
Kefir has a better ability to donate protons than non-
fermented milk. Therefore, kefir can give protection 
against free radicals and thus increase SOD activity 
(Niccolai et al., 2019; Bellikci-Koyu et al., 2019; Zhang, 
Wu and Fei, 2016). 
Oxidative stress is closely related to various diseases, 
including diabetes. The body will naturally develop 
enzymatic and nonenzymatic antioxidant defenses to 
balance oxidative stress. However, this endogenous 
protection might fail to prevent the overpopulated free 
radicals that are generated as the disease progresses. 
Therefore, exogenous antioxidant-rich foods such as kefir 
and spirulina are beneficial to back up the role of 




 The present study has demonstrated that kefir-spirulina 
showed high nutrient content, strong antioxidant capacity, 
relatively low alcohol concentration, and an ability to 
control glycemic status and SOD activity of a diabetic rat 
model. Based on the properties exhibited by kefir-spirulina 
in this study, kefir-spirulina has the potential for use in the 
dietary approach to the management of diabetes. 
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